UPDATE - UBS Initiates Coverage on Robert Half (RHI) with a Buy; Pure-play on Growth in Professional Sector
Tweet Send to a FriendGet Alerts RHI Hot Sheet
Price: $35.27 -1.4%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade RHI Now!
UPDATE - UBS initiates coverage on Robert Half (NYSE: RHI) with a Buy rating. PT $34.
UBS analyst said, "RHI benefits from both a cyclical recovery of professional temporary staffing (revenues are still 15-20% below pre-recession peak) and secular demand for labor cost flexibility. The company is also well-positioned to capture demand for skilled IT professionals, particularly among its core small/mid-sized client base."
"RHI trades at 0.9x forward EV/sales, a significant but well-deserved premium to peers given higher EBITDA margin and faster growth prospects, thanks to its focus on the professional niche."
To see more ratings on RHI, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
UBS analyst said, "RHI benefits from both a cyclical recovery of professional temporary staffing (revenues are still 15-20% below pre-recession peak) and secular demand for labor cost flexibility. The company is also well-positioned to capture demand for skilled IT professionals, particularly among its core small/mid-sized client base."
"RHI trades at 0.9x forward EV/sales, a significant but well-deserved premium to peers given higher EBITDA margin and faster growth prospects, thanks to its focus on the professional niche."
To see more ratings on RHI, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- JMP Securities Starts Galena Biopharma (GALE) at Market Outperform
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
